|Articles|August 14, 2008
Drug Designed to Fight MS Could Target Viral Infections
Advertisement
Reuters is reporting today that a new drug, FTY720, also called fingolimod, that Novartis AG is testing in individuals with multiple sclerosis could also tackle some viral infections, including perhaps including meningitis and perhaps even the AIDS virus. For the complete article,
Source: Reuters
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Bug of the Month: The Quiet Guest in the Dust
2
Continuous Photohydrolysis Disinfection Cuts MDROs, COVID-19, and Hospital Transfers in Long-Term Care, Study Finds
3
Manual Cleaning vs Automation: Achieving Consistent Cleanliness for Ultrasound Device Reprocessing
4
Influenza D and Canine Coronavirus: Why Underrecognized Animal Viruses May Be the Next Respiratory Threat
5